Ignite Creation Date:
2024-07-17 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06481683
Status:
TERMINATED
Last Update Posted:
2024-07-03
First Post:
2024-06-24
Brief Title:
Maternal Serum Stathmin-1 Levels in Preeclampsia
Sponsor:
Burak Yücel Special Clinic
Organization:
Burak Yücel Special Clinic
Study Overview
Official Title:
Evaluation of Maternal Serum Stathmin-1 Levels as a Biomarker in Preeclampsia and Severe Preeclampsia
Status:
TERMINATED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The study was terminated due to the change of the clinic where the principal investigator was employed
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MSSLP
Brief Summary:
The goal of this observational study is to investigate maternal serum Stathmin-1 levels in pregnancies affected by preeclampsia compared to healthy gestations
The main questions it aims to answer are
1 What are the maternal serum Stathmin-1 levels in pregnancies with preeclampsia
2 How do Stathmin-1 levels differ between preeclampsia with severe features and uncomplicated pregnancies
Researchers will compare Stathmin-1 levels in pregnancies with preeclampsia and preeclampsia with severe features to those in a control group of healthy pregnancies to assess differences in biomarker levels
Participants will undergo blood sample collection at 32-34 weeks of gestation Have their blood samples processed for Stathmin-1 level measurement using ELISA
The main questions it aims to answer are
1 What are the maternal serum Stathmin-1 levels in pregnancies with preeclampsia
2 How do Stathmin-1 levels differ between preeclampsia with severe features and uncomplicated pregnancies
Researchers will compare Stathmin-1 levels in pregnancies with preeclampsia and preeclampsia with severe features to those in a control group of healthy pregnancies to assess differences in biomarker levels
Participants will undergo blood sample collection at 32-34 weeks of gestation Have their blood samples processed for Stathmin-1 level measurement using ELISA
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None